Advisory Research’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-3,809
Closed -$285K 386
2023
Q3
$285K Sell
3,809
-1,124
-23% -$86.5K 0.04% 384
2023
Q2
$380K Buy
+4,933
New +$393K 0.05% 341
2018
Q1
Sell
-3,036
Closed -$217K 391
2017
Q4
$217K Buy
3,036
+295
+11% +$22.4K ﹤0.01% 397
2017
Q3
$222K Sell
2,741
-175
-6% -$13.4K ﹤0.01% 416
2017
Q2
$206K Buy
+2,916
New +$194K ﹤0.01% 422
2016
Q4
Sell
-33,912
Closed -$2.68M 361
2016
Q3
$2.68M Sell
33,912
-372
-1% -$30.2K 0.04% 135
2016
Q2
$2.86M Sell
34,284
-41,465
-55% -$3.68M 0.05% 134
2016
Q1
$6.96M Sell
75,749
-197,735
-72% -$17.8M 0.13% 112
2015
Q4
$27.7M Sell
273,484
-1,535
-0.6% -$160K 0.42% 73
2015
Q3
$27M Buy
275,019
+757
+0.3% +$84.1K 0.38% 75
2015
Q2
$32.1M Sell
274,262
-13,597
-5% -$1.49M 0.36% 78
2015
Q1
$28.2M Sell
287,859
-36,750
-11% -$3.73M 0.31% 80
2014
Q4
$30.6M Buy
324,609
+137,987
+74% +$14.3M 0.32% 77
2014
Q3
$19.9M Buy
186,622
+184,192
+7,580% +$18M 0.19% 114
2014
Q2
$201K Sell
2,430
-8
-0.3% -$623 ﹤0.01% 308
2014
Q1
$173K Buy
+2,438
New +$191K ﹤0.01% 319

Other funds holding GILD

Advisory Research's GILD Position: Q4 2023 in Review

Advisory Research sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 3,809 shares — an estimated $285K sold.

Advisory Research first reported a position in GILD in Q1 2014 and held it in 16 quarters. The position peaked at $32.1M in Q2 2015. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.

  • Advisory Research reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
  • Advisory Research sold 3,809 Gilead Sciences shares in Q4 2023, an estimated $285K.
  • Advisory Research first reported a position in Gilead Sciences in Q1 2014 and held it in 16 quarters.
  • Advisory Research's Gilead Sciences position peaked at $32.1M in Q2 2015.
  • 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.

Based on Advisory Research's 13F filing for Q4 2023, filed 13 Feb 2024.